Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11955595rdf:typepubmed:Citationlld:pubmed
pubmed-article:11955595lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C2350463lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C1425775lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C0332516lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C2699744lld:lifeskim
pubmed-article:11955595lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:11955595pubmed:issue14lld:pubmed
pubmed-article:11955595pubmed:dateCreated2002-4-16lld:pubmed
pubmed-article:11955595pubmed:abstractTextNatural killer (NK) cells function through a diverse array of cell-surface natural killer receptors (NCRs). NCRs specific for classical and non-classical MHC class I proteins, expressed in complex patterns of inhibitory and activating isoforms on overlapping, but distinct, subsets of NK cells, play an important role in immunosurveillance against cells that have reduced MHC class I expression as a result of infection or transformation. Another NCR, NKG2D, is an activating NCR first identified on NK cells, but subsequently found on macrophages and a variety of T cell types. NKG2D ligands in rodents include the MHC class I-like proteins RAE-1 and H60 and, in humans, ULBPs and the cell stress-inducible proteins MICA and MICB. NKG2D-MIC and -RAE-1 recognition events have been implicated in anti-viral and -tumor immune responses. Crystallographic analyses of NKG2D-MICA and -RAE-1 complexes reveal an unusual mode of recognition that apparently tolerates a surprising degree of ligand plasticity while generating affinities that are among the strongest TCR- or NCR-ligand affinities, thus, far described.lld:pubmed
pubmed-article:11955595pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:languageenglld:pubmed
pubmed-article:11955595pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:citationSubsetIMlld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11955595pubmed:statusMEDLINElld:pubmed
pubmed-article:11955595pubmed:monthMaylld:pubmed
pubmed-article:11955595pubmed:issn0161-5890lld:pubmed
pubmed-article:11955595pubmed:authorpubmed-author:StrongRoland...lld:pubmed
pubmed-article:11955595pubmed:issnTypePrintlld:pubmed
pubmed-article:11955595pubmed:volume38lld:pubmed
pubmed-article:11955595pubmed:ownerNLMlld:pubmed
pubmed-article:11955595pubmed:authorsCompleteYlld:pubmed
pubmed-article:11955595pubmed:pagination1029-37lld:pubmed
pubmed-article:11955595pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:meshHeadingpubmed-meshheading:11955595...lld:pubmed
pubmed-article:11955595pubmed:year2002lld:pubmed
pubmed-article:11955595pubmed:articleTitleAsymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.lld:pubmed
pubmed-article:11955595pubmed:affiliationDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. rstrong@fhcrc.orglld:pubmed
pubmed-article:11955595pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11955595pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11955595pubmed:publicationTypeReviewlld:pubmed
pubmed-article:11955595pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11955595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11955595lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11955595lld:pubmed